Clinical trial
TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
NCT00356980 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00356980 |
|---|---|
| Title | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects With Advanced Solid Organ Malignancies |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Other |
| Interventions | colloidal gold-bound tumor necrosis factor, pharmacological study |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jul 27, 2006 |
| Last update posted | Mar 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: